| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile
|
Salmeron-Villalobos, Julia
|
|
|
6 |
16 |
p. 4661-4674
|
article
|
| 2 |
CD34 + -selected stem cell boost can safely improve cytopenias following CAR T-cell therapy
|
Mullanfiroze, Khushnuma
|
|
|
6 |
16 |
p. 4715-4718
|
article
|
| 3 |
Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAF V600E
|
Milne, Paul
|
|
|
6 |
16 |
p. 4901-4904
|
article
|
| 4 |
Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis
|
Shafagati, Nazila
|
|
|
6 |
16 |
p. 4740-4762
|
article
|
| 5 |
Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans
|
Gnatenko, Dmitri V.
|
|
|
6 |
16 |
p. 4884-4900
|
article
|
| 6 |
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
|
Hasan, Aisha N.
|
|
|
6 |
16 |
p. 4859-4872
|
article
|
| 7 |
Editorial Board
|
|
|
|
6 |
16 |
p. i
|
article
|
| 8 |
Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19
|
Neal, Matthew D.
|
|
|
6 |
16 |
p. 4710-4714
|
article
|
| 9 |
HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition
|
Moison, Céline
|
|
|
6 |
16 |
p. 4793-4806
|
article
|
| 10 |
ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis
|
Giustozzi, Michela
|
|
|
6 |
16 |
p. 4873-4883
|
article
|
| 11 |
ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD
|
Xiao, Zunyu
|
|
|
6 |
16 |
p. 4782-4792
|
article
|
| 12 |
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study
|
Alderuccio, Juan P.
|
|
|
6 |
16 |
p. 4736-4739
|
article
|
| 13 |
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
|
Jaeger, Ulrich
|
|
|
6 |
16 |
p. 4816-4820
|
article
|
| 14 |
Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma
|
Little, Jessica S.
|
|
|
6 |
16 |
p. 4821-4830
|
article
|
| 15 |
Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21
|
Zaaboub, Rim
|
|
|
6 |
16 |
p. 4691-4704
|
article
|
| 16 |
Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
|
Robin, Marie
|
|
|
6 |
16 |
p. 4763-4772
|
article
|
| 17 |
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
|
Lesueur, Paul
|
|
|
6 |
16 |
p. 4807-4815
|
article
|
| 18 |
Revision of RUNX1 variant curation rules
|
Feurstein, Simone
|
|
|
6 |
16 |
p. 4726-4730
|
article
|
| 19 |
Rural-urban disparities in place of death in hematologic malignancies in the United States, 2003 to 2019
|
Hussaini, S. M. Qasim
|
|
|
6 |
16 |
p. 4731-4734
|
article
|
| 20 |
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
|
Rejeski, Kai
|
|
|
6 |
16 |
p. 4719-4725
|
article
|
| 21 |
Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease
|
Chopra, Maya
|
|
|
6 |
16 |
p. 4831-4833
|
article
|
| 22 |
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
|
van Rhee, Frits
|
|
|
6 |
16 |
p. 4773-4781
|
article
|
| 23 |
Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma
|
Colombo, Anthony R.
|
|
|
6 |
16 |
p. 4675-4690
|
article
|
| 24 |
The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS
|
Hofman, Isabel Juliana F.
|
|
|
6 |
16 |
p. 4705-4709
|
article
|
| 25 |
The odyssey of pacritinib in myelofibrosis
|
Venugopal, Sangeetha
|
|
|
6 |
16 |
p. 4905-4913
|
article
|
| 26 |
Traumatic vessel injuries initiating hemostasis generate high shear conditions
|
Yakusheva, Alexandra A.
|
|
|
6 |
16 |
p. 4834-4846
|
article
|
| 27 |
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis
|
Vogiatzi, Fotini
|
|
|
6 |
16 |
p. 4847-4858
|
article
|
| 28 |
Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229.
|
|
|
|
6 |
16 |
p. 4735
|
article
|
Journal description